Detailed information for compound 233268

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 364.398 | Formula: C20H20N4O3
  • H donors: 3 H acceptors: 2 LogP: 2.13 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: NC(=N)Nc1ccc(cc1)C1CC(=C)OC(=O)C1NC(=O)c1ccccc1
  • InChi: 1S/C20H20N4O3/c1-12-11-16(13-7-9-15(10-8-13)23-20(21)22)17(19(26)27-12)24-18(25)14-5-3-2-4-6-14/h2-10,16-17H,1,11H2,(H,24,25)(H4,21,22,23)
  • InChiKey: DAGLKJZKVSWYJY-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Bos taurus Alpha-chymotrypsin Starlite/ChEMBL References
Bos taurus Trypsin I Starlite/ChEMBL References
Homo sapiens plasminogen activator, urokinase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum ko:K09639 transmembrane protease, serine 8, putative Get druggable targets OG5_126639 All targets in OG5_126639
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) Get druggable targets OG5_126639 All targets in OG5_126639
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126639 All targets in OG5_126639
Brugia malayi Trypsin family protein Get druggable targets OG5_126639 All targets in OG5_126639
Onchocerca volvulus Get druggable targets OG5_126639 All targets in OG5_126639
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) Get druggable targets OG5_126639 All targets in OG5_126639
Onchocerca volvulus Get druggable targets OG5_126639 All targets in OG5_126639
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126639 All targets in OG5_126639
Schistosoma japonicum ko:K09639 transmembrane protease, serine 8, putative Get druggable targets OG5_126639 All targets in OG5_126639

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Drosophila melanogaster CG4815 gene product from transcript CG4815-RA Alpha-chymotrypsin   245 aa 216 aa 24.1 %
Drosophila melanogaster CG30288 gene product from transcript CG30288-RC Alpha-chymotrypsin   245 aa 236 aa 30.1 %
Drosophila melanogaster CG18420 gene product from transcript CG18420-RA Alpha-chymotrypsin   245 aa 233 aa 26.2 %
Echinococcus granulosus glycoprotein Antigen 5 Alpha-chymotrypsin   245 aa 297 aa 22.2 %
Loa Loa (eye worm) hypothetical protein Alpha-chymotrypsin   245 aa 287 aa 21.6 %
Drosophila melanogaster Jonah 65Aiii Alpha-chymotrypsin   245 aa 232 aa 32.8 %
Drosophila melanogaster Trypsin 29F Alpha-chymotrypsin   245 aa 238 aa 38.2 %
Schistosoma japonicum Enteropeptidase, putative Alpha-chymotrypsin   245 aa 268 aa 23.9 %
Schistosoma japonicum Cercarial protease precursor (EC 3.4.21.-) (Cercarial elastase), putative Alpha-chymotrypsin   245 aa 220 aa 20.9 %
Drosophila melanogaster CG30287 gene product from transcript CG30287-RA Alpha-chymotrypsin   245 aa 247 aa 32.0 %
Echinococcus granulosus enteropeptidase Alpha-chymotrypsin   245 aa 279 aa 26.5 %
Drosophila melanogaster CG3916 gene product from transcript CG3916-RA Alpha-chymotrypsin   245 aa 235 aa 35.3 %
Drosophila melanogaster CG31326 gene product from transcript CG31326-RA Alpha-chymotrypsin   245 aa 270 aa 25.9 %
Drosophila melanogaster CG3505 gene product from transcript CG3505-RA Alpha-chymotrypsin   245 aa 252 aa 28.2 %
Schistosoma mansoni cercarial elastase (S01 family) Alpha-chymotrypsin   245 aa 213 aa 26.8 %
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) Alpha-chymotrypsin   245 aa 247 aa 31.6 %
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) Alpha-chymotrypsin   245 aa 300 aa 25.7 %
Drosophila melanogaster CG31267 gene product from transcript CG31267-RA Alpha-chymotrypsin   245 aa 235 aa 31.5 %
Onchocerca volvulus Alpha-chymotrypsin   245 aa 250 aa 25.2 %
Drosophila melanogaster CG33458 gene product from transcript CG33458-RA Alpha-chymotrypsin   245 aa 255 aa 27.1 %
Brugia malayi Trypsin family protein Alpha-chymotrypsin   245 aa 256 aa 21.5 %
Drosophila melanogaster Jonah 65Aii Alpha-chymotrypsin   245 aa 234 aa 31.2 %
Mycobacterium tuberculosis Membrane-associated serine protease Trypsin I   246 aa 203 aa 20.7 %
Drosophila melanogaster CG13744 gene product from transcript CG13744-RA Alpha-chymotrypsin   245 aa 265 aa 34.0 %
Echinococcus granulosus subfamily S1A unassigned peptidase S01 family Alpha-chymotrypsin   245 aa 300 aa 27.3 %
Drosophila melanogaster CG9673 gene product from transcript CG9673-RB Alpha-chymotrypsin   245 aa 243 aa 25.9 %
Drosophila melanogaster Jonah 99Ci Alpha-chymotrypsin   245 aa 234 aa 29.5 %
Schistosoma japonicum ko:K09639 transmembrane protease, serine 8, putative Alpha-chymotrypsin   245 aa 225 aa 32.4 %
Drosophila melanogaster CG31220 gene product from transcript CG31220-RB Alpha-chymotrypsin   245 aa 268 aa 23.9 %
Loa Loa (eye worm) hypothetical protein Alpha-chymotrypsin   245 aa 252 aa 21.8 %
Drosophila melanogaster CG18180 gene product from transcript CG18180-RA Alpha-chymotrypsin   245 aa 232 aa 31.0 %
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) Alpha-chymotrypsin   245 aa 239 aa 36.8 %
Drosophila melanogaster Jonah 66Ci Alpha-chymotrypsin   245 aa 231 aa 31.6 %
Drosophila melanogaster CG10405 gene product from transcript CG10405-RB Alpha-chymotrypsin   245 aa 237 aa 31.6 %
Schistosoma japonicum ko:K01346 pancreatic elastase II [EC3.4.21.71], putative Alpha-chymotrypsin   245 aa 314 aa 24.5 %
Drosophila melanogaster Spatzle-Processing Enzyme Alpha-chymotrypsin   245 aa 275 aa 29.1 %
Echinococcus multilocularis glycoprotein Antigen 5 Alpha-chymotrypsin   245 aa 296 aa 23.0 %
Schistosoma japonicum ko:K09637 transmembrane protease, serine 6, putative Alpha-chymotrypsin   245 aa 240 aa 30.4 %
Echinococcus multilocularis enteropeptidase Alpha-chymotrypsin   245 aa 279 aa 27.2 %
Schistosoma mansoni cercarial elastase (S01 family) Alpha-chymotrypsin   245 aa 213 aa 26.8 %
Drosophila melanogaster CG30083 gene product from transcript CG30083-RB Alpha-chymotrypsin   245 aa 246 aa 29.7 %
Schistosoma mansoni aminopeptidase PILS (M01 family) Alpha-chymotrypsin   245 aa 300 aa 23.3 %
Drosophila melanogaster CG32277 gene product from transcript CG32277-RA Alpha-chymotrypsin   245 aa 237 aa 27.0 %
Drosophila melanogaster CG9733 gene product from transcript CG9733-RB Alpha-chymotrypsin   245 aa 261 aa 29.1 %
Schistosoma mansoni cercarial elastase (S01 family) Alpha-chymotrypsin   245 aa 218 aa 22.9 %
Drosophila melanogaster CG4914 gene product from transcript CG4914-RA Alpha-chymotrypsin   245 aa 238 aa 34.9 %
Drosophila melanogaster CG17239 gene product from transcript CG17239-RB Alpha-chymotrypsin   245 aa 225 aa 32.9 %
Echinococcus multilocularis transmembrane protease serine 3 Alpha-chymotrypsin   245 aa 266 aa 32.7 %
Echinococcus multilocularis Mastin Alpha-chymotrypsin   245 aa 302 aa 26.2 %
Schistosoma japonicum ko:K09639 transmembrane protease, serine 8, putative Alpha-chymotrypsin   245 aa 239 aa 33.5 %
Drosophila melanogaster CG5909 gene product from transcript CG5909-RA Alpha-chymotrypsin   245 aa 259 aa 29.3 %
Echinococcus granulosus Mastin Alpha-chymotrypsin   245 aa 302 aa 26.2 %
Onchocerca volvulus Alpha-chymotrypsin   245 aa 240 aa 27.5 %
Brugia malayi Trypsin family protein Alpha-chymotrypsin   245 aa 249 aa 25.7 %
Schistosoma mansoni cercarial elastase (S01 family) Alpha-chymotrypsin   245 aa 237 aa 24.5 %
Schistosoma japonicum Transmembrane protease, serine 9, putative Alpha-chymotrypsin   245 aa 231 aa 22.5 %
Drosophila melanogaster CG33465 gene product from transcript CG33465-RC Alpha-chymotrypsin   245 aa 221 aa 19.0 %
Onchocerca volvulus Alpha-chymotrypsin   245 aa 251 aa 22.3 %
Echinococcus granulosus transmembrane protease serine 3 Alpha-chymotrypsin   245 aa 270 aa 31.9 %
Drosophila melanogaster CG14990 gene product from transcript CG14990-RA Alpha-chymotrypsin   245 aa 245 aa 29.0 %
Brugia malayi Trypsin family protein Alpha-chymotrypsin   245 aa 245 aa 24.5 %
Echinococcus granulosus Mastin plasminogen activator, urokinase 414 aa 340 aa 24.4 %
Onchocerca volvulus Alpha-chymotrypsin   245 aa 237 aa 23.6 %
Drosophila melanogaster CG11313 gene product from transcript CG11313-RC Alpha-chymotrypsin   245 aa 255 aa 29.0 %
Echinococcus multilocularis subfamily S1A unassigned peptidase (S01 family) Alpha-chymotrypsin   245 aa 300 aa 27.7 %
Drosophila melanogaster CG30323 gene product from transcript CG30323-RB Alpha-chymotrypsin   245 aa 218 aa 21.6 %
Neospora caninum glycine cleavage T-protein domain containing protein, putative Trypsin I   246 aa 203 aa 21.7 %
Drosophila melanogaster CG34436 gene product from transcript CG34436-RA Alpha-chymotrypsin   245 aa 244 aa 24.6 %
Drosophila melanogaster betaTrypsin Alpha-chymotrypsin   245 aa 239 aa 40.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis farnesyl pyrophosphate synthase 0.0236 0.9025 1
Loa Loa (eye worm) polyprenyl synthetase 0.0236 0.9025 0.8867
Plasmodium vivax geranylgeranyl pyrophosphate synthase 0.0236 0.9025 1
Mycobacterium ulcerans geranylgeranyl pyrophosphate synthase 0.0236 0.9025 1
Loa Loa (eye worm) hypothetical protein 0.0251 1 1
Onchocerca volvulus 0.0251 1 1
Giardia lamblia Farnesyl diphosphate synthase 0.0236 0.9025 0.5
Trypanosoma cruzi farnesyl pyrophosphate synthase, putative 0.0236 0.9025 1
Plasmodium falciparum geranylgeranyl pyrophosphate synthase, putative 0.0236 0.9025 1
Trypanosoma cruzi farnesyl pyrophosphate synthase 0.0236 0.9025 1
Mycobacterium tuberculosis Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) 0.0236 0.9025 1
Trichomonas vaginalis geranylgeranyl pyrophosphate synthase, putative 0.0236 0.9025 0.5
Schistosoma mansoni farnesyl pyrophosphate synthase 0.0236 0.9025 0.9025
Echinococcus multilocularis thymidylate synthase 0.0114 0.14 0.1551
Echinococcus granulosus thymidylate synthase 0.0114 0.14 0.1551
Loa Loa (eye worm) hypothetical protein 0.0251 1 1
Echinococcus granulosus farnesyl pyrophosphate synthase 0.0236 0.9025 1
Leishmania major farnesyl pyrophosphate synthase 0.0236 0.9025 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0251 1 1
Schistosoma mansoni bifunctional dihydrofolate reductase-thymidylate synthase 0.0114 0.14 0.14
Mycobacterium leprae PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) 0.0114 0.14 0.5
Trypanosoma brucei farnesyl pyrophosphate synthase 0.0236 0.9025 1
Mycobacterium ulcerans geranylgeranyl pyrophosphate synthase 0.0236 0.9025 1
Brugia malayi Polyprenyl synthetase family protein 0.0236 0.9025 0.8867
Toxoplasma gondii polyprenyl synthetase superfamily protein 0.0236 0.9025 1
Onchocerca volvulus 0.02 0.6784 0.626
Trichomonas vaginalis geranylgeranyl pyrophosphate synthase, putative 0.0236 0.9025 0.5
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0251 1 1
Trichomonas vaginalis geranylgeranyl diphosphate synthase, putative 0.0236 0.9025 0.5

Activities

Activity type Activity value Assay description Source Reference
Ka (binding) = 4.83 min-1 Compound was tested for the rate constant of acylation against the enzyme plasmin ChEMBL. 1447734
Ka (binding) = 4.83 min-1 Compound was tested for the rate constant of acylation against the enzyme plasmin ChEMBL. 1447734
Ka (binding) = 9.51 min-1 Compound was tested for the rate constant of acylation against the enzyme thrombin ChEMBL. 1447734
Ka (binding) = 9.51 min-1 Compound was tested for the rate constant of acylation against the enzyme thrombin ChEMBL. 1447734
Ka (binding) = 10.2 min-1 Compound was tested for the rate constant of acylation against the enzyme trypsin ChEMBL. 1447734
Ka (binding) = 10.2 min-1 Compound was tested for the rate constant of acylation against the enzyme trypsin ChEMBL. 1447734
Kd (binding) min-1 Compound was tested for the rate constant of deacylation against alpha-chymotrypsin; kd was too fast to measure ChEMBL. 1447734
Kd (binding) fast 0 min-1 Compound was tested for the rate constant of deacylation against alpha-chymotrypsin; kd was too fast to measure ChEMBL. 1447734
Kd (binding) = 0.002 min-1 Compound was tested for the rate constant of deacylation against Urokinase-type plasminogen activator ChEMBL. 1447734
Kd (binding) = 0.002 min-1 Compound was tested for the rate constant of deacylation against Urokinase-type plasminogen activator ChEMBL. 1447734
Kd (binding) = 0.015 min-1 Compound was tested for the rate constant of deacylation against the enzyme trypsin ChEMBL. 1447734
Kd (binding) = 0.015 min-1 Compound was tested for the rate constant of deacylation against the enzyme trypsin ChEMBL. 1447734
Ki (binding) = 0.46 uM Compound was tested for its binding affinity against the enzyme alpha-chymotrypsin ChEMBL. 1447734
Ki (binding) = 0.46 uM Compound was tested for its binding affinity against the enzyme alpha-chymotrypsin ChEMBL. 1447734
Ki (binding) = 6 uM Compound was tested for its binding affinity against the enzyme Urokinase-type plasminogen activator ChEMBL. 1447734
Ki (binding) = 6 uM Compound was tested for its binding affinity against the enzyme Urokinase-type plasminogen activator ChEMBL. 1447734
Ki (binding) = 10 uM Compound was tested for its binding affinity against the enzyme trypsin ChEMBL. 1447734
Ki (binding) = 10 uM Compound was tested for its binding affinity against the enzyme trypsin ChEMBL. 1447734

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.